Showing results (31-40 of 120) with videos related to

Sort By:
Pageof 12
Metabolism: Clinical and Experimental|July 15, 2006
High serum high-sensitivity C-reactive protein concentrations are associated with relative cardiac sympathetic overactivity during the early morning period in type 2 diabetic patients with metabolic syndromeYoshimasa Aso, Sadao Wakabayashi, Tomoki Nakano, et al.
The American Journal of the Medical Sciences|March 16, 2005
Endogenous endophthalmitis and disseminated intravascular coagulation complicating a Klebsiella pneumoniae perirenal abscess in a patient with type 2 diabetesKohzo Takebayashi, Sachiko Matsumoto, Yayoi Nakagawa, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|March 24, 2009
High-molecular-weight adiponectin does not predict cardiovascular events in patients with type 2 diabetesKatarzyna Krzyzanowska, Yoshimasa Aso, Friedrich Mittermayer, et al.
Southern Medical Journal|October 1, 2004
Microscopic polyangiitis presenting with liver dysfunction preceding rapidly progressive necrotizing glomerulonephritisKohzo Takebayashi, Yoshimasa Aso, Hiroshi Kitamura, et al.
Journal of Pharmacological Sciences|September 29, 2012
Miglitol, an anti-diabetic drug, inhibits oxidative stress-induced apoptosis and mitochondrial ROS over-production in endothelial cells by enhancement of AMP-activated protein kinaseChie Aoki, Kunihiro Suzuki, Kazunori Yanagi, et al.
Internal Medicine (Tokyo, Japan)|April 19, 2016
Postprandial Reactive Hypoglycemia Treated with a Low-dose Alpha-glucosidase Inhibitor: Voglibose May Suppress Oxidative Stress and Prevent Endothelial DysfunctionKunihiro Suzuki, Daisuke Katsura, Masaaki Sagara, et al.
Diabetology & Metabolic Syndrome|July 28, 2016
Empagliflozin (an SGLT2 inhibitor), alone or in combination with linagliptin (a DPP-4 inhibitor), prevents steatohepatitis in a novel mouse model of non-alcoholic steatohepatitis and diabetesTeruo Jojima, Takanori Tomotsune, Toshie Iijima, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|August 20, 2014
Bezafibrate, a peroxisome proliferator-activated receptor α agonist, decreases circulating CD14(+)CD16(+) monocytes in patients with type 2 diabetesTomoko Terasawa, Yoshimasa Aso, Kyoko Omori, et al.
Internal Medicine (Tokyo, Japan)|March 20, 2015
Insulinoma in a patient with chronic renal failure due to type 2 diabetes mellitus treated effectively with diazoxideMasanori Shimizu, Kunihiro Suzuki, Kohei Tsuchida, et al.
The Journal of Clinical Endocrinology and Metabolism|November 9, 2004
Elevated pregnancy-associated plasma protein-a in sera from type 2 diabetic patients with hypercholesterolemia: associations with carotid atherosclerosis and toe-brachial indexYoshimasa Aso, Ki-ichi Okumura, Sadao Wakabayashi, et al.
Pageof 12